Holistic Integrative Oncology（HIO，eISSN:2731-4529; CN12-1481/R73）是由中国抗癌协会与Springer Nature出版集团于2021年强强联合打造的一本英文大刊，主编为中国抗癌协会理事长樊代明院士。HIO入选了2022年中国科技期刊卓越行动计划高起点新刊项目，是面向全球开放的自由获取同行评议期刊，设有CACA指南、专家述评、研究综述和原创论著等栏目。医学伦理学专题文章已正式上线，敬请各位读者阅读、引用与分享！
本专题目录
01 Guideline for ethics review of clinical trials
文章类型：Guideline
引用格式：Medical Ethics Society of China Anti-Cancer Association., Hong, M. & Yan, Z. Guideline for ethics review of clinical trials. Holist Integ Oncol 4, 6 (2025). https://doi.org/10.1007/s44178-024-00122-8
扫描上方二维码，进入详细阅读
02 The development and challenges of Investigator-Initiated Trials (IITs) in China
文章类型：Commentary
引用格式：Hong, M., Yan, Z. The development and challenges of Investigator-Initiated Trials (IITs) in China. Holist Integ Oncol 3, 57 (2024). https://doi.org/10.1007/s44178-024-00123-7
扫描上方二维码，进入详细阅读
03 The relationship between ethics and innovation: specifically regarding the application and ethical considerations of artificial intelligence in animal models
文章类型：Review
引用格式：Yin, H., Li, Q., Yang, S. et al. The relationship between ethics and innovation: specifically regarding the application and ethical considerations of artificial intelligence in animal models. Holist Integ Oncol 3, 61 (2024).https://doi.org/10.1007/s44178-024-00134-4
扫描上方二维码，进入详细阅读
04 Practice and reflections on regional mutual recognition of clinical research ethics review——based on survey results from medical and health institutions in Jiangsu Province
文章类型：Original Research
引用格式：Liu, X., Hong, Q., Huang, J. et al. Practice and reflections on regional mutual recognition of clinical research ethics review——based on survey results from medical and health institutions in Jiangsu Province. Holist Integ Oncol 3, 49 (2024). https://doi.org/10.1007/s44178-024-00125-5
扫描上方二维码，进入详细阅读
05 Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey
文章类型：Original Research
引用格式：Wang, Y., Sun, T., He, Z. et al. Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey. Holist Integ Oncol 3, 51 (2024). https://doi.org/10.1007/s44178-024-00124-6
扫描上方二维码，进入详细阅读
06 Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB’s empirical perspective
文章类型：Original Research
引用格式：Liu, X., Song, Z., Tang, S. et al. Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB’s empirical perspective. Holist Integ Oncol 3, 54 (2024). https://doi.org/10.1007/s44178-024-00126-4
扫描上方二维码，进入详细阅读
07 Perceptions of clinicians and research ethics boards regarding ethical issues in investigator-initiated trials: a multicenter qualitative study in China
文章类型：Original Research
引用格式：Li, J., Yu, H., Wei, X. et al. Perceptions of clinicians and research ethics boards regarding ethical issues in investigator-initiated trials: a multicenter qualitative study in China. Holist Integ Oncol 3, 59 (2024). https://doi.org/10.1007/s44178-024-00132-6
扫描上方二维码，进入详细阅读
